Werewolf Therapeutics Stock Technical Analysis
| HOWL Stock | USD 0.71 0.04 5.97% |
As of the 28th of January, Werewolf Therapeutics maintains the Market Risk Adjusted Performance of (0.42), standard deviation of 7.32, and Mean Deviation of 4.63. Werewolf Therapeutics technical analysis makes it possible for you to employ past prices and volume data with the intention to determine a pattern that calculates the direction of the company's future prices. Please check out Werewolf Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Werewolf Therapeutics is priced fairly, providing market reflects its latest price of 0.71 per share. As Werewolf Therapeutics is a penny stock we also advise to confirm its jensen alpha numbers.
Werewolf Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Werewolf, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to WerewolfWerewolf Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. Market participants price Werewolf higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Werewolf Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Werewolf Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Werewolf Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Werewolf Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Werewolf Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
Werewolf Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Werewolf Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Werewolf Therapeutics.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Werewolf Therapeutics on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Werewolf Therapeutics or generate 0.0% return on investment in Werewolf Therapeutics over 90 days. Werewolf Therapeutics is related to or competes with IO Biotech, Spruce Biosciences, OUTLOOK THERAPEUTICS, Adicet Bio, NRX Pharmaceuticals, Lite Strategy, and OS Therapies. Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the bodys immune... More
Werewolf Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Werewolf Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Werewolf Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 51.9 | |||
| Value At Risk | (7.63) | |||
| Potential Upside | 7.69 |
Werewolf Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Werewolf Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Werewolf Therapeutics' standard deviation. In reality, there are many statistical measures that can use Werewolf Therapeutics historical prices to predict the future Werewolf Therapeutics' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.46) | |||
| Treynor Ratio | (0.43) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Werewolf Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Werewolf Therapeutics January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.42) | |||
| Mean Deviation | 4.63 | |||
| Coefficient Of Variation | (915.04) | |||
| Standard Deviation | 7.32 | |||
| Variance | 53.56 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.46) | |||
| Treynor Ratio | (0.43) | |||
| Maximum Drawdown | 51.9 | |||
| Value At Risk | (7.63) | |||
| Potential Upside | 7.69 | |||
| Skewness | (2.20) | |||
| Kurtosis | 12.22 |
Werewolf Therapeutics Backtested Returns
Werewolf Therapeutics shows Sharpe Ratio of -0.11, which attests that the company had a -0.11 % return per unit of risk over the last 3 months. Werewolf Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Werewolf Therapeutics' Standard Deviation of 7.32, market risk adjusted performance of (0.42), and Mean Deviation of 4.63 to validate the risk estimate we provide. The firm maintains a market beta of 1.9, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Werewolf Therapeutics will likely underperform. At this point, Werewolf Therapeutics has a negative expected return of -0.8%. Please make sure to check out Werewolf Therapeutics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Werewolf Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.76 |
Good predictability
Werewolf Therapeutics has good predictability. Overlapping area represents the amount of predictability between Werewolf Therapeutics time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Werewolf Therapeutics price movement. The serial correlation of 0.76 indicates that around 76.0% of current Werewolf Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | -0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Werewolf Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Werewolf Therapeutics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Werewolf Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Werewolf Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Werewolf Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Werewolf Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Werewolf Therapeutics price pattern first instead of the macroeconomic environment surrounding Werewolf Therapeutics. By analyzing Werewolf Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Werewolf Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Werewolf Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Werewolf Therapeutics January 28, 2026 Technical Indicators
Most technical analysis of Werewolf help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Werewolf from various momentum indicators to cycle indicators. When you analyze Werewolf charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.42) | |||
| Mean Deviation | 4.63 | |||
| Coefficient Of Variation | (915.04) | |||
| Standard Deviation | 7.32 | |||
| Variance | 53.56 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.46) | |||
| Treynor Ratio | (0.43) | |||
| Maximum Drawdown | 51.9 | |||
| Value At Risk | (7.63) | |||
| Potential Upside | 7.69 | |||
| Skewness | (2.20) | |||
| Kurtosis | 12.22 |
Werewolf Therapeutics January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Werewolf stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 156,780 | ||
| Daily Balance Of Power | 0.33 | ||
| Rate Of Daily Change | 1.06 | ||
| Day Median Price | 0.74 | ||
| Day Typical Price | 0.73 | ||
| Price Action Indicator | (0.01) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Werewolf Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. Market participants price Werewolf higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Werewolf Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Werewolf Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Werewolf Therapeutics' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Werewolf Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Werewolf Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.